These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 23936062)
21. Co-delivery of hydrophilic and hydrophobic drugs by micelles: a new approach using drug conjugated PEG-PCLNanoparticles. Danafar H; Rostamizadeh K; Davaran S; Hamidi M Drug Dev Ind Pharm; 2017 Nov; 43(11):1908-1918. PubMed ID: 28737462 [TBL] [Abstract][Full Text] [Related]
22. Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel. Sun B; Feng SS Nanomedicine (Lond); 2009 Jun; 4(4):431-45. PubMed ID: 19505246 [TBL] [Abstract][Full Text] [Related]
23. The multilayer nanoparticles formed by layer by layer approach for cancer-targeting therapy. Oh KS; Lee H; Kim JY; Koo EJ; Lee EH; Park JH; Kim SY; Kim K; Kwon IC; Yuk SH J Control Release; 2013 Jan; 165(1):9-15. PubMed ID: 23103984 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles. Kheiri Manjili H; Ghasemi P; Malvandi H; Mousavi MS; Attari E; Danafar H Eur J Pharm Biopharm; 2017 Jul; 116():17-30. PubMed ID: 27756682 [TBL] [Abstract][Full Text] [Related]
25. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy. Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645 [TBL] [Abstract][Full Text] [Related]
26. Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles. Liu Q; Li RT; Qian HQ; Wei J; Xie L; Shen J; Yang M; Qian XP; Yu LX; Jiang XQ; Liu BR Biomaterials; 2013 Sep; 34(29):7191-203. PubMed ID: 23806972 [TBL] [Abstract][Full Text] [Related]
27. [Small interfering RNA delivery mediated by mPEG-PCL-g-PEI polymer nanoparticles]. Huang W; Lü M; Gao ZG; Jin MJ; Yang CQ Yao Xue Xue Bao; 2011 Mar; 46(3):344-9. PubMed ID: 21626792 [TBL] [Abstract][Full Text] [Related]
28. Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Zeng X; Tao W; Mei L; Huang L; Tan C; Feng SS Biomaterials; 2013 Aug; 34(25):6058-67. PubMed ID: 23694904 [TBL] [Abstract][Full Text] [Related]
29. Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: An in vitro-in vivo study. Gajbhiye KR; Gajbhiye V; Siddiqui IA; Pilla S; Soni V Sci Rep; 2017 Sep; 7(1):11086. PubMed ID: 28894228 [TBL] [Abstract][Full Text] [Related]
30. Copolymer nanoparticles composed of sulfobetaine and poly(ε-caprolactone) as novel anticancer drug carriers. Cao J; Xiu KM; Zhu K; Chen YW; Luo XL J Biomed Mater Res A; 2012 Aug; 100(8):2079-87. PubMed ID: 22581715 [TBL] [Abstract][Full Text] [Related]
31. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors. Guo F; Wu J; Wu W; Huang D; Yan Q; Yang Q; Gao Y; Yang G J Nanobiotechnology; 2018 Jul; 16(1):57. PubMed ID: 30012166 [TBL] [Abstract][Full Text] [Related]
33. Amphiphilic methoxy poly(ethylene glycol)-b-poly(ε-caprolactone)-b-poly(2-dimethylaminoethyl methacrylate) cationic copolymer nanoparticles as a vector for gene and drug delivery. Yue X; Qiao Y; Qiao N; Guo S; Xing J; Deng L; Xu J; Dong A Biomacromolecules; 2010 Sep; 11(9):2306-12. PubMed ID: 20666510 [TBL] [Abstract][Full Text] [Related]
34. Enhanced in vivo antitumor efficacy of dual-functional peptide-modified docetaxel nanoparticles through tumor targeting and Hsp90 inhibition. Jiang Y; Yang N; Zhang H; Sun B; Hou C; Ji C; Zheng J; Liu Y; Zuo P J Control Release; 2016 Jan; 221():26-36. PubMed ID: 26643616 [TBL] [Abstract][Full Text] [Related]
35. Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy. Huang L; Chen H; Zheng Y; Song X; Liu R; Liu K; Zeng X; Mei L Integr Biol (Camb); 2011 Oct; 3(10):993-1002. PubMed ID: 21938302 [TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin. Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659 [TBL] [Abstract][Full Text] [Related]
37. Enzyme sensitive, surface engineered nanoparticles for enhanced delivery of camptothecin. Yu H; Chen J; Liu S; Lu Q; He J; Zhou Z; Hu Y J Control Release; 2015 Oct; 216():111-20. PubMed ID: 26282096 [TBL] [Abstract][Full Text] [Related]
38. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
39. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer. Zhang D; Zou Z; Ren W; Qian H; Cheng Q; Ji L; Liu B; Liu Q Pharm Dev Technol; 2018 Jan; 23(1):33-40. PubMed ID: 29069711 [TBL] [Abstract][Full Text] [Related]
40. Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer. Wang Y; Liu P; Du J; Sun Y; Li F; Duan Y J Biomater Sci Polym Ed; 2013; 24(10):1219-32. PubMed ID: 23713424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]